These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21653312)

  • 1. Pulmonary hypertension in HIV-infected individuals.
    Hsue PY; Bolger AF; Martin JN
    Clin Infect Dis; 2011 Jul; 53(1):96; author reply 96-7. PubMed ID: 21653312
    [No Abstract]   [Full Text] [Related]  

  • 2. High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy.
    Mondy KE; Gottdiener J; Overton ET; Henry K; Bush T; Conley L; Hammer J; Carpenter CC; Kojic E; Patel P; Brooks JT;
    Clin Infect Dis; 2011 Feb; 52(3):378-86. PubMed ID: 21217185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease and therapeutic drug-related cardiovascular consequences in HIV-infected patients.
    Fisher SD; Kanda BS; Miller TL; Lipshultz SE
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):383-94. PubMed ID: 22149317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review.
    Lambert CT; Sandesara PB; Hirsh B; Shaw LJ; Lewis W; Quyyumi AA; Schinazi RF; Post WS; Sperling L
    HIV Med; 2016 Jun; 17(6):411-24. PubMed ID: 26611380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy.
    Currier JS; Lundgren JD; Carr A; Klein D; Sabin CA; Sax PE; Schouten JT; Smieja M;
    Circulation; 2008 Jul; 118(2):e29-35. PubMed ID: 18566319
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of cardiovascular disease in HIV-infected patients.
    Das S
    J Antimicrob Chemother; 2010 Mar; 65(3):386-9. PubMed ID: 20026610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary disease in HIV-infected adults in the era of antiretroviral therapy.
    Fitzpatrick ME; Kunisaki KM; Morris A
    AIDS; 2018 Jan; 32(3):277-292. PubMed ID: 29194119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy-associated diseases are common in the long-term.
    Lanzafame M; Lattuada E; Zoppini G; Vento S
    AIDS Res Hum Retroviruses; 2011 Sep; 27(9):931-2. PubMed ID: 21182461
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of highly active antiretroviral therapy on cardiovascular involvement in children with human immunodeficiency virus infection.
    Plebani A; Esposito S; Pinzani R; Fesslova V; Bojanin J; Salice P; Rossi M; Principi N
    Pediatr Infect Dis J; 2004 Jun; 23(6):559-63. PubMed ID: 15194840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV, HAART, and hyperlipidemia: balancing the effects.
    Sherer R
    J Acquir Immune Defic Syndr; 2003 Oct; 34 Suppl 2():S123-9. PubMed ID: 14703941
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV-associated pulmonary arterial hypertension: from bedside to the future.
    Correale M; Palmiotti GA; Lo Storto MM; Montrone D; Foschino Barbaro MP; Di Biase M; Lacedonia D
    Eur J Clin Invest; 2015 May; 45(5):515-28. PubMed ID: 25715739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of highly active antiretroviral therapy on ischemic cardiovascular disease in patients with HIV-1 infection.
    Torre D; Pugliese A; Orofino G
    Clin Infect Dis; 2002 Sep; 35(5):631-2. PubMed ID: 12173141
    [No Abstract]   [Full Text] [Related]  

  • 13. Heterosexual transmission of HIV-1 infection in UK.
    Barbaro G
    Lancet; 2001 Oct; 358(9291):1458. PubMed ID: 11705525
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular Disease and HIV Infection.
    Klein D; Hurley LB; Sidney S
    N Engl J Med; 2003 Nov; 349(19):1869-70; author reply 1869-70. PubMed ID: 14602888
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular disease and HIV infection: host, virus, or drugs?
    Martínez E; Larrousse M; Gatell JM
    Curr Opin Infect Dis; 2009 Feb; 22(1):28-34. PubMed ID: 19532078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular manifestations of HIV infection.
    Barbaro G
    Circulation; 2002 Sep; 106(11):1420-5. PubMed ID: 12221062
    [No Abstract]   [Full Text] [Related]  

  • 17. Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection.
    Loke WC; Spittle MF; Mitchell S; Kulasegaram R
    Int J STD AIDS; 2006 Aug; 17(8):565-6. PubMed ID: 16925908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
    Jantarapakde J; Phanuphak N; Chaturawit C; Pengnonyang S; Mathajittiphan P; Takamtha P; Dungjun N; Pinyakorn S; Pima W; Prasithsirikul W; Phanuphak P
    AIDS Patient Care STDS; 2014 Jul; 28(7):331-40. PubMed ID: 24914459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of metabolic complications and cardiovascular risk in HIV-infected patients.
    Blanco F; San Román J; Vispo E; López M; Salto A; Abad V; Soriano V
    AIDS Rev; 2010; 12(4):231-41. PubMed ID: 21179187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular manifestations in patients infected with the human immunodeficiency virus].
    Hajjar LA; Calderaro D; Yu PC; Giuliano I; Lima EM; Barbaro G; Caramelli B
    Arq Bras Cardiol; 2005 Nov; 85(5):363-77. PubMed ID: 16358156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.